Literature DB >> 2446117

Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes.

D Shalloway1, P J Johnson, E O Freed, D Coulter, W A Flood.   

Abstract

pp60c-src, the cellular homolog of the Rous sarcoma virus transforming protein, does not completely transform cells even when present at high levels, but has been shown to be involved in polyomavirus-induced transformation when activated by polyomavirus middle T (pmt)-antigen binding. Here we show that cotransfection, but not solo transfection, of expression plasmids for c-src and either adenovirus E1A, v-myc, c-myc, or the 5' half of polyomavirus large T (pltN) antigen into NIH 3T3 cells induces anchorage-independent growth, enhanced focus formation, and, for pltN cotransfection, tumorigenicity in adult NFS mice. Enhancement of transformation was not observed with polyomavirus small t (pst) antigen. Cotransfection of c-src with pltN induced modification of pp60c-src that altered its electrophoretic mobility and in vivo phosphorylation state and stimulated its in vitro kinase activity. Similar alterations were not seen after c-src-E1A cotransfection, suggesting that at least two different mechanisms of enhancement are involved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446117      PMCID: PMC368012          DOI: 10.1128/mcb.7.10.3582-3590.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Forms of pp60v-src isolated from Rous sarcoma virus-transformed cells.

Authors:  M S Collett; S K Belzer
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  Development of anti-pp60src serum with antigen produced in Escherichia coli.

Authors:  T M Gilmer; R L Erikson
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

4.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

5.  Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture.

Authors:  H E Ruley
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

6.  Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60v-src and pp60c-src.

Authors:  R C Parker; H E Varmus; J M Bishop
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

7.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

8.  Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses.

Authors:  L A Lipsich; A J Lewis; J S Brugge
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

9.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus.

Authors:  R Swanstrom; R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  The complex of polyoma virus middle-T antigen and pp60c-src.

Authors:  S A Courtneidge; A E Smith
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  16 in total

Review 1.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

2.  Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene.

Authors:  E White; R Cipriani
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A.

Authors:  P Yaciuk; J K Choi; D Shalloway
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

5.  Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein.

Authors:  E White; R Cipriani
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

6.  Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.

Authors:  R S Ames; B Holskin; M Mitcho; D Shalloway; M J Chen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival.

Authors:  Hui Li; Xianyong Ma; Jinglan Wang; Jason Koontz; Marisa Nucci; Jeffrey Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

8.  Highly efficient focus formation by Rous sarcoma virus on adenovirus type 12 E1A-transformed rat 3Y1 cells.

Authors:  K Shiroki; M Hamaguchi; S Kawai
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.

Authors:  Rajib Rajhans; Sujit Nair; Alan H Holden; Rakesh Kumar; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties.

Authors:  Luwen Zhang; Jun Zhang; Que Lambert; Channing J Der; Luis Del Valle; Judith Miklossy; Kamel Khalili; You Zhou; Joseph S Pagano
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.